Brief: Sino Biopharmaceutical Enters Joint Venture With Tempo Scan
27/07/2026 09:38
BRIEF-Sino Biopharmaceutical Enters Joint Venture With Tempo Scan July 27 (Reuters) - Sino Biopharmaceutical Ltd 1177.HK:
ENTERS JOINT VENTURE WITH TEMPO SCAN TO ESTABLISH PT TEMPO CTTQ BIOPHARMACEUTICAL INDONESIA
JOINT VENTURE TO FOCUS ON REGULATORY, CLINICAL, COMMERCIALIZATION, AND LOCAL MANUFACTURING IN INDONESIA
HOLDS 51% STAKE IN JOINT VENTURE, TEMPO SCAN HOLDS 49%
Further company coverage: 1177.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sino Biopharmaceutical
See all newsHong Kong stocks end higher on pharma, tech gains
Hong Kong stocks climb, led by pharmaceutical, tech stocks
Brief: Sino Biopharmaceutical Says China's CDE Accepts NDA For TQH2722 Injection
Brief: Sino Biopharmaceutical China CDE Accepts New Drug Application For TQB2102 Injection
Sino Biopharmaceutical climbs on plan to raise stake in core unit